Antitumor activity of titanocene amino acid complexes

BioMetals

Volumn 9, Issue 3, 1996, Pages 267-271

  Köpf Maier, Petra ^a   Tornieporth Oetting, I C ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Antitumor activity; Ehrlich ascites tumor; Mechanism of action; Titanocene amino acid complexes

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; 4 FLUOROPHENYLALANINE; ALANINE DERIVATIVE; AMINO ACID DERIVATIVE; CHLORIDE; GLYCINE DERIVATIVE; PHENYLALANINE DERIVATIVE; TITANOCENE; TITANOCENE DICHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LIFESPAN; MOUSE; NONHUMAN;

AMINO ACIDS; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; CARCINOMA, EHRLICH TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MICE; MODELS, MOLECULAR; ORGANOMETALLIC COMPOUNDS;

ANIMALIA;

EID: 0030018189     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00817926     Document Type: Article

References (14)

1. Berdel WE, Schmoll HJ, Scheulen ME, et al. 1994 Phase I clinical trial of titanocene dichloride in adults with advanced solid tumors. J Cancer Res Clin Oncol 120 (Suppl), R-172.
2. Johnson AD, Mairs RJ, Gaze MN, Sass G, Huxham IM. 1995 Electron spectroscopic imaging of organic compounds using PC-based energy sequence imaging software. Micros Microanal Microstruct 6, 65-77.
3. Klapötke TM, Köpf H, Tornieporth-Oetting IC, White PS. 1994 Synthesis, characterization, and structural investigation of the first bioinorganic titanocene(IV) α-amino acid complexes prepared from the antitumor agent titanocene dichloride. Organometallics 13, 3628-3633.
4. Köpf-Maier P. 1990 Intracellular localization of titanium with xenografted sensitive human tumors after treatment with the antitumor agent titanocene dichloride. J Struct Biol 105, 35-45.
5. Kopf-Maier P. 1993 Antitumor bis(cyclopentadienyl)metal complexes. In: Keppler BK, ed. Metal Complexes in Cancer Chemotherapy. Weinheim: VCH Verlagsgesellschaft; 259-296.
6. Köpf-Maier P. 1994 Complexes of metals other than platinum as antitumor agents. Eur J Clin Pharmacol 47, 1-16.
7. Köpf-Maier P, Klapötke T. 1992 Ionic rhenocene derivatives with antitumor activity. Cancer Chemother Pharmacol 29, 361-366.
8. Kopf-Maier P, Köpf H. 1988 Transition and main-group metal cyclopentadienyl complexes: preclinical studies on a series of antitumor agents of different structure type. Struct Bond 70, 103-185.
9. Köpf-Maier P, Köpf H. 1994 Organometallic titanium, vanadium, niobium, molybdenum and rhenium complexes - early transition metal antitumor drugs. In: Fricker SP, ed. Metal Compounds in Cancer Therapy. London: Chapman & Hall; 109-146.
10. Korfel A, Schmoll HJ, Scheulen ME, et al. 1995 Klinische Phase-I-Studie mit Titanocen-dichlorid bei Patienten mit soliden Tumoren. Akt Onkol 84, 51-59.
11. 2Ti or DNA-CpTi adducts depending on pH. J Am Chem Soc 112, 8949-8952.
12. 2 with nucleic acid constituents. J Med Chem 37, 1936-1941.
13. 5-cyclopentadienyl)titanium(IV) with nucleosides. Inorg Chim Acta 151, 125-128.
14. Tornieporth-Oetting IC, White PS. 1995 Ionic titanocene(IV) α-amino acid complexes of DL-phenylalanine and DL-4-fluorophenylalanine: synthesis, characterization, and investigation of the antimicrobial behavior toward Escherichia coli. Organometallics 14, 1632-1636.